Skip to main content
Veterinary Medicines

EMDOFLUXIN 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES

Authorised
  • Flunixin meglumine

Product identification

Medicine name:
EMDOFLUXIN 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES
Emdofluxin 50 mg/ml, injekcinis tirpalas galvijams, kiaulėms ir arkliams
Active substance:
  • Flunixin meglumine
Target species:
  • Cattle
  • Pig
  • Equid
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        31
        day
      • Milk
        36
        hour
    • Pig
      • Meat and offal
        20
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        24
        hour
    • Equid
      • Meat and offal
        10
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/20/2610/001-003
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0417/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • Estonia
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

RV2610.pdf

Lithuanian (PDF)
Published on: 26/07/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."